Marietta Wu

Marietta Wu was the founder of Zai Lab Ltd., founded in 2014, and served as Director from 2017 to 2018.
Current jobs include Managing Director at Quan Capital Management LLC and Burrill & Co. Venture Capital; Non-Executive Director at Crescendo Biologics Ltd.; Director at China Healthcare Consortium Ltd., MEDx Translational Medicine Co., Ltd., Jing Medicine Technology Shanghai Ltd., Kira Pharmaceuticals (Hong Kong) Ltd., Eluminex Biosciences (Suzhou) Ltd., Innoforce Pharmaceuticals Co. Ltd., and Shanghai Rarestone Health Tech Group Co., Ltd.; and Secretary General at The BayHelix Group.
Former jobs include Independent Director at General Biologicals Corp., Director at Taiwan Liposome Co., Ltd., Principal at Eli Lilly & Co. and Edwards Lifesciences Corp., and Chief Operating Officer at Waterstone Pharmaceuticals, Inc. Education includes an MBA from the University of Michigan, a doctorate from the University of Toledo Medical Center, and an undergraduate degree from Shanghai Jiao Tong University.